Signal Mechanism of the Protective Effect of Combined Preconditioning by Amtizole and Moderate Hypoxia
- Authors: Levchenkova O.S.1, Novikov V.E.1, Abramova E.S.1, Feoktistova Z.A.1
- 
							Affiliations: 
							- Department of Pharmacology, Smolensk State Medical University
 
- Issue: Vol 164, No 3 (2018)
- Pages: 320-323
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239575
- DOI: https://doi.org/10.1007/s10517-018-3981-5
- ID: 239575
Cite item
Abstract
The content of regulatory proteins involved in adaptation to hypoxia and ischemia was studied in brain rat homogenate under conditions of normoxia and after bilateral ligation of the common carotid arteries. Preconditioning with amtizole in combination with moderate hypoxia increased the levels of HIF-1α, erythropoietin, vascular endothelial growth factor under conditions of normoxia. During experimental ischemia, combined preconditioning led to stabilization of the content of these regulatory proteins at the level of intact control and to a decrease in glycogen synthase-3β kinase activity. This pattern of changes in regulatory proteins was noted during the early and late periods of preconditioning.
About the authors
O. S. Levchenkova
Department of Pharmacology, Smolensk State Medical University
							Author for correspondence.
							Email: os.levchenkova@gmail.com
				                					                																			                												                	Russian Federation, 							Smolensk						
V. E. Novikov
Department of Pharmacology, Smolensk State Medical University
														Email: os.levchenkova@gmail.com
				                					                																			                												                	Russian Federation, 							Smolensk						
E. S. Abramova
Department of Pharmacology, Smolensk State Medical University
														Email: os.levchenkova@gmail.com
				                					                																			                												                	Russian Federation, 							Smolensk						
Zh. A. Feoktistova
Department of Pharmacology, Smolensk State Medical University
														Email: os.levchenkova@gmail.com
				                					                																			                												                	Russian Federation, 							Smolensk						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					